CAPRICOR THERAPEUTICS, INC. (CAPR) Shareholders’ equity 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) shareholders’ equity at each fiscal year-end, per SEC filings.
$305.8MFY2025 · since FY2016: -$4.0M → $305.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $305.8M | +110.2% |
| FY2024 | $145.5M | +543.6% |
| FY2023 | $22.6M | +91.8% |
| FY2022 | $11.8M | -62.4% |
| FY2021 | $31.4M | +11.2% |
| FY2020 | $28.2M | +312.3% |
| FY2019 | $6.8M | +48.2% |
| FY2018 | $4.6M | -58.9% |
| FY2017 | $11.2M | +380.5% |
| FY2016 | -$4.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice